Short description
BioActor develops proprietary health ingredients for use in functional foods, medical nutrition, and dietary supplements.
Description
BioActor develops proprietary health ingredients for use in functional foods, medical nutrition and dietary supplements. All these ingredients address chronic health concerns, such as diabetes,osteoporosis, cardiovascular disease, that would benefit from preventative measures through the diet. BioActor's product development strategy relies on three simple tenets: a new health ingredient must be based on a patentable scientific discovery; it must be food grade from a natural and renewable source; and its health effect must be clinically proven. BioActor's first product, BONOLIVE, a first in class bone health ingredient that is clinically proven to stimulate bone producing cells, is a great example of this strategy and will be launched in the USA this year. BioActor successfully implemented its product development strategy by establishing alliances with top nutrition research institutes (e.g. INRA, CSIC, Maastricht University, UCL, Ghent University) and by establishing production partnerships with industrial players to shorten the path to market.
Last funding
Nopepepe
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Maastricht, Limburg, The Netherlands, Europe
Founded on
January 1, 2005
Non-profit?
No
Acquired?
No
Employees count
1-10
Investors
Cannot Access, Noaccessforu, Cannot Access, Noaccess
Sign in for full access
Founders
Hans van der Saag
Funding rounds count
1
Portfolio organisations count
Nopepepe, Cannot Access
Sign in for full access